ADH1C Facilitates Cisplatin Resistance of Lung Adenocarcinoma Cells
DNA and Cell Biology · 01.06.2022 · 41 (6) · 631-640
DOI: 10.1089/dna.2021.0877 ↗Kurz gefasst
Fachartikel in der Zeitschrift DNA and Cell Biology, erschienen am 01.06.2022. Verfasst von Feng Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Wenzhou, China.
- Department of Respiratory, The First People's Hospital of Yu hang District, Hangzhou, Zhejiang, China.
ORCID-Profile: Feng Jiang, Yumin Wang
Zitieren
APA
Jiang, F., Shen, Q., Zhang, F., Fu, J., Hu, L., Wang, J., Zhou, H., Chen, J., & Wang, Y. (2022). ADH1C Facilitates Cisplatin Resistance of Lung Adenocarcinoma Cells. DNA and Cell Biology, 41(6), 631-640. https://doi.org/10.1089/dna.2021.0877
Vancouver
Jiang F, Shen Q, Zhang F, Fu J, Hu L, Wang J, et al. ADH1C Facilitates Cisplatin Resistance of Lung Adenocarcinoma Cells. DNA and Cell Biology. 2022;41(6):631-640. doi:10.1089/dna.2021.0877
BibTeX
@article{Jiang2022,
author = {Jiang, Feng and Shen, Qiang and Zhang, Fan and Fu, Jiali and Hu, Lijuan and Wang, Junjun and Zhou, Huixin and Chen, Jian and Wang, Yumin},
title = {ADH1C Facilitates Cisplatin Resistance of Lung Adenocarcinoma Cells},
journal = {DNA and Cell Biology},
year = {2022},
volume = {41},
number = {6},
pages = {631--640},
doi = {10.1089/dna.2021.0877}
}
EUVIMED